• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23378 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2007     National Institute for Health and Care Excellence (NICE) Thoracoscopic excision of mediastinal parathyroid tumours. NICE interventional procedures guidance 247
2011     National Institute for Health and Care Excellence (NICE) Thoracoscopic exclusion of the left atrial appendage (with or without surgical ablation) for non-valvular atrial fibrillation for the prevention of thromboembolism. NICE interventional procedures guidance 400
2011     National Institute for Health and Care Excellence (NICE) Thoracoscopic repair of congenital diaphragmatic hernia in neonates
2011     National Institute for Health and Care Excellence (NICE) Thoracoscopic repair of congenital diaphragmatic hernia in neonates. NICE interventional procedures guidance 379
2007     National Institute for Health and Care Excellence (NICE) Thoracoscopically assisted mitral valve surgery. NICE interventional procedures guidance 245
2006     National Institute for Health and Care Excellence (NICE) Thoracoscopically assisted oesophagectomy
2020     NIHR Health Technology Assessment programme Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT
2003     Adelaide Health Technology Assessment (AHTA) Thoratec heartmate (R) left ventricular assist device for patients with heart failure who are ineligible for heart transplantation
1996     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Thoravision - systematic review, expert panel
2019     NIHR Health Technology Assessment programme Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation
2005     HAYES, Inc. Three-dimensional and four-dimensional ultrasound for diagnosis of fetal head abnormalities
2006     HAYES, Inc. Three-dimensional and four-dimensional ultrasound for extrafetal and maternal structures in pregnancy
2006     HAYES, Inc. Three-dimensional and four-dimensional ultrasound for fetal cardiovascular diagnosis
2005     HAYES, Inc. Three-dimensional and four-dimensional ultrasound for fetal growth and volume measurements
2005     HAYES, Inc. Three-dimensional and four-dimensional ultrasound for fetal limbs and skeletal structures
2005     HAYES, Inc. Three-dimensional and four-dimensional ultrasound for high-risk pregnancies and routine screening
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Three-dimensional electroanatomical mapping in arrhythmia ablation
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Three-wheel and four-wheel scooters: alternatives to powered wheelchairs?
2008     Belgian Health Care Knowledge Centre (KCE) Threshold values for cost-effectiveness in health care
2004     National Institute for Clinical Excellence (NICE) Thrombin injections for pseudoaneurysms
2004     National Institute for Health and Care Excellence (NICE) Thrombin injections for pseudoaneurysms. NICE interventional procedures guidance 60
2005     Danish Institute for Health Services Research (DSI) Thrombo-Base. A technology assessment of a decision support system and a clinical database for anticoagulant treatment
2014     Penn Medicine Center for Evidence-based Practice (CEP) Thromboelastography
2011     Penn Medicine Center for Evidence-based Practice (CEP) Thromboelastography for determining transfusion requirements
2013     Penn Medicine Center for Evidence-based Practice (CEP) Thromboelastography-guided heparin use for the prevention of venous thromboembolism
1999     Norwegian Knowledge Centre for the Health Services (NOKC) Thrombolitic medication for treatment of stroke
2011     NIHR Horizon Scanning Centre (NIHR HSC) ThromboLUX™ for determining platelet quality
2011     NIHR Horizon Scanning Centre (NIHR HSC) ThromboLUX™ for determining platelet quality
1997     Scottish Health Purchasing Information Centre (SHPIC) Thrombolysis for heart attacks
1997     Scottish Health Purchasing Information Centre (SHPIC) Thrombolysis for heart attacks[TEST COPY]
2003     The Swedish Council on Health Technology Assessment (SBU) Thrombolysis with plasminogen activator (rtPA) in stroke - early assessment briefs (Alert)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Thrombolytic drugs for cardiac arrest: a review of the clinical effectiveness
1995     University HealthSystem Consortium (UHC) Thrombolytic therapy
2015     NIHR Health Technology Assessment programme Thrombolytic therapy for pulmonary embolism
1992     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Thrombolytic therapy: current status - summary
2000     University HealthSystem Consortium (UHC) Thrombolytics for MI
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Thrombophilia testing for women who have had pregnancy loss: clinical evidence, cost-effectiveness, and guidelines
2009     NIHR Health Technology Assessment programme Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis
2011     Norwegian Knowledge Centre for the Health Services (NOKC) Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery
2024     NIHR Health Technology Assessment programme Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research
2008     HAYES, Inc. Thrombosis panel for risk assessment for venous thromboembolism (VTE) or obstetric complications
2017     HAYES, Inc. ThyGenX and ThyraMIR (Interpace Diagnostics)
2005     NIHR Horizon Scanning Centre (NIHR HSC) Thymalfasin (Zadaxin) for hepatitis C virus - horizon scanning review
2000     University HealthSystem Consortium (UHC) Thymosin alpha-1
2012     NIHR Horizon Scanning Centre (NIHR HSC) Thymosin beta-4 for dry eye syndrome
2014     NIHR Horizon Scanning Centre (NIHR HSC) Thymosin beta-4 for epidermolysis bullosa
2008     HAYES, Inc. Thymus transplantation for treatment of children with DiGeorge syndrome
2022     Swiss Federal Office of Public Health (FOPH) Thyroid function tests for the diagnosis of suspected primary or secondary thyroid dysfunction
2012     HAYES, Inc. Thyroid hormone receptor beta (THRB) gene testing in resistance to thyroid hormone (RTH)
1992     Health Services Utilization and Research Commission (HSURC) Thyroid testing
2008     NIHR Horizon Scanning Centre (NIHR HSC) Ticagrelor (AZD6140) for acute coronary syndrome
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ticagrelor (Brilique) for preventing thombotic events in patients with acute ischaemic stroke or high risk transient ischaemic attack
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ticagrelor (Brilique) for secondary prevention of cardiovascular disease events in patients with prior myocardial infarction
2016     National Institute for Health and Care Excellence (NICE) Ticagrelor for preventing atherothrombotic events after myocardial infarction. NICE technology appraisal guidance 420
2019     Agency for Care Effectiveness (ACE) Ticagrelor for preventing thrombotic events in adults with acute coronary syndromes
2011     NIHR Health Technology Assessment programme Ticagrelor for the treatment of acute coronary syndromes
2011     National Institute for Health and Care Excellence (NICE) Ticagrelor for the treatment of acute coronary syndromes. NICE technology appraisal guidance 236
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Tigecycline: usefulness of its clinical application
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tildrakizumab for moderate to severe plaque psoriasis
2019     National Institute for Health and Care Excellence (NICE) Tildrakizumab for treating moderate to severe plaque psoriasis. NICE technology appraisal guidance 575
2001     Centre for Clinical Effectiveness (CCE) Time to commencement of oral feeding following laryngectomy
2008     NIHR Health Technology Assessment programme Time to full publication of studies of anti-cancer medicines for breast cancer, and the potential for publication bias: a short systematic review
2008     NIHR Health Technology Assessment programme Time to full publication of studies of anti-cancer medicines for breast cancer, and the potential for publication bias: a short systematic review
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Timing of antibiotic therapy for neisseria gonorrhoeae infection
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Timing of enoxaparin administration for the prophylaxis of venous thromboembolism: clinical evidence and guidelines
2017     NIHR Health Technology Assessment programme Timing of surgical intervention for developmental dysplasia of the hip: a randomised controlled trial (Hip 'Op)
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Timing of umbilical cord clamping for neonatal and maternal outcomes
2019     Penn Medicine Center for Evidence-based Practice (CEP) Timing of valve replacement for patients with infective endocarditis and intracranial embolism
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Timothy grass standardized allergenic extract (Grastek — Merck Canada Inc.) indication: allergic rhinitis (grass pollen)
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Tin-117m DTPA
2022     WorkSafeBC Tinnitus and the COVID-19 vaccine
1998     Wessex Institute for Health Research and Development (WIHRD) Tinnitus retraining therapy
2004     Washington State Department of Labor and Industries (WSDLI) Tinnitus retraining therapy
2004     WorkSafeBC Tinnitus retraining therapy
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Tinnitus retraining therapy: a review of the clinical effectiveness
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tinzaparin sodium (Innohep®)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tinzaparin versus dalteparin or enoxaparin for the treatment of venous thromboembolism in adults: safety and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium bromide
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Tiotropium bromide
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium compared with ipratropium for patients with moderate to severe chronic obstructive pulmonary disease: a review of the clinical effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium compared with ipratropium for patients with moderate to severe chronic obstructive pulmonary disease: a review of the clinical effectiveness
2001     NIHR Horizon Scanning Centre (NIHR HSC) Tiotropium for COPD - horizon scanning review
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium for moderate-to-severe chronic obstructive pulmonary disease: a review of the clinical effectiveness and cost-effectiveness
2009     Belgian Health Care Knowledge Centre (KCE) Tiotropium in the treatment of chronic obstructive pulmonary disease health technology assessment
2009     Belgian Health Care Knowledge Centre (KCE) Tiotropium in the treatment of chronic obstructive pulmonary disease: health technology assessment
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Tiotropium: a potential replacement for ipratropium in patients with COPD
2019     Penn Medicine Center for Evidence-based Practice (CEP) Tip positioning of short-term central venous catheters
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tipranavir (Aptivus®)
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tipranavir (Aptivus®) capsules
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tipranavir (Aptivus®) oral solution
2002     NIHR Horizon Scanning Centre (NIHR HSC) Tirapazamine for non-small cell lung cancer - horizon scanning review
2023     National Institute for Health and Care Excellence (NICE) Tirzepatide for treating type 2 diabetes. NICE technology appraisal guidance 924
2022     Institute for Clinical and Economic Review (ICER) Tirzepatide for type 2 diabetes
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Tisagenlecleucel for acute lymphoblastic leukemia and diffuse large b-cell lymphoma: clinical report
2022     National Institute for Health and Care Excellence (NICE) Tisagenlecleucel for treating follicular lymphoma after 2 or more therapies (terminated appraisal). NICE technology appraisal guidance 842
2018     National Institute for Health and Care Excellence (NICE) Tisagenlecleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years. NICE technology appraisal guidance 554
2023     National Institute for Health and Care Excellence (NICE) Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies (terminated appraisal). NICE technology appraisal guidance 933
2019     National Institute for Health and Care Excellence (NICE) Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies. NICE technology appraisal guidance 567
2008     HAYES, Inc. Tisseel VH (Baxter Healthcare Corp.) for cardiac surgery
2008     HAYES, Inc. Tisseel VH (Baxter Healthcare Corp.) for noncardiac surgeries with problematic hemostasis